FDA issued a Warning Letter to Shilpa Medicare Limited on 10/9/2020 for a later inspection.
483 Shilpa Medicare Aug 2015

483 Shilpa Medicare Aug 2015

Tajah Blackburn FDA, Felix Maldonado FDA, Meisha Waters FDA, Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Shilpa Medicare - Polepally, Jadcherla, India facility and issued inspectional observations (via FDA 483) on 26 Aug 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Aug 2015
  • Location: Polepally, Jadcherla, India
  • FEI: 3009876430
Add To Cart